Promoter holding
64.27%
ML
Maxwell Life Science Limited - Due diligence report
A 360° intelligence report on Maxwell Life Science Limited: trust score, financial health, credit view, compliance, directors, growth and di…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Maxwell Life Science Limited — 360° Intelligence Report
Generated from MCA filings & public records79/100
Trust Score
Low Risk
Maxwell Life Science Limited is assessed as Low Risk with a Trust Score of 79/100. Maxwell Life Science Limited is an active public limited indian non-government company incorporated in 2004, operating in the Chemicals sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.
Report generated on 02 Aug 2026 from the latest processed filings. Maxwell Life Science Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
79/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
64/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Open charges exceed net worth - secured lenders rank ahead.
- Elevated gearing (D/E 38%).
- Profitable - internal accruals available.
Charges position: 7 open (21.37 cr) · 8 satisfied (14.61 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 4 | 48.0 cr |
| The Shamrao Vithal Co-Op. Bank Ltd. | 3 | 48.0 cr |
| The Bharat Co-Operative Bank (Mumbai) Limited | 4 | 48.0 cr |
| The Bharat Co-Operative Bank(Mumbai) Ltd | 4 | 48.0 cr |
Compliance Score: 64/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 2 court forum(s).
- 2 auditor resignation(s) filed - latest: J.P.J. ASSOCIATES LLP on 2024-09-22.
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SANJAY BASTIMAL SURANA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Rajendra Runwal | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Vijay Kumar Sagarmal Singhavi | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HARSHITA SUDHAKAR SHETTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NEETU SANJAY SURANA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Nayankant Hasmukhlal Gadoya | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Sunil Atmaram Vasaikar | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- No disqualified or deactivated DINs.
- 3 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
8 allotment(s) · 6 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
Key managerial personnel: SANJAY BASTIMAL SURANA (Managing Director) · NEETU SANJAY SURANA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Net margin improved to 61%.
EPFO headcount growing - hiring signal.
Operating for 22+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
7 open charge(s) registered - assets are encumbered.
2 auditor resignation(s) on record - review the stated reasons.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment57/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 7 open charge(s) of 21.37 cr already registered.
- Compliance gaps should be priced into terms.
Investor view82/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 6 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events04 Sep 2025
Charge created
Others - 1.32 cr
Charge created
Others - 31.50 Lakh
23 May 2025
Charge created
Others - 3.00 cr
01 Apr 2025
Director ceased
Nayankant Hasmukhlal Gadoya
20 Mar 2025
Director appointed
Nayankant Hasmukhlal Gadoya (Director)
13 Mar 2025
Director appointed
Sunil Atmaram Vasaikar (Cfo)
11 Mar 2025
Director ceased
PIYUSH NARAYAN TRIVEDI
02 Jan 2025
Director appointed
HARSHITA SUDHAKAR SHETTY (Company Secretary)
21 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
18 Mar 2024
Director appointed
Rajendra Runwal (Director)
Director appointed
Vijay Kumar Sagarmal Singhavi (Director)
05 Feb 2024
Director ceased
SANJAY BASTIMAL SURANA
01 Nov 2023
Charge created
The Bharat Co-Operative Bank(Mumbai) Ltd - 70.00 Lakh
31 Jan 2023
Charge created
The Bharat Co-Operative Bank(Mumbai) Ltd - 1.25 cr
10
Key Observations
Auto-generated from the data aboveRevenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - leverage worth monitoring.
Net worth is positive.
7 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 8 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Mody Chemi Pharma Limited | U24100MH2002PLC136659 | Mumbai, Maharashtra, India |
| Ultrafine Mineral & Admixtures Private Limited | U24100MH2020PTC338575 | Nagpur, Maharashtra, India |
| Star Hi Herbs | U01117KA2008PTC046084 | Bangalore, Karnataka, India |
| Lewens Labs Private Limited | U24233GJ2014PTC081091 | Bharuch, Gujarat, India |
| Lyka Labs | L24230GJ1976PLC008738 | Ankleshwar, Gujarat, India |
| M.M. Remedies Private Limited | U24231UP1998PTC023497 | Llucknow, Uttar Pradesh, India |
| Raja Explosives Private Limited | U24292TZ1996PTC007607 | Erode, Tamil Nadu, India |
| Soham Polymers Private Limited | U24110MH1995PTC088223 | Thane, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Maxwell Life Science Limited before audits and certifications: compliance score 64/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Maxwell Life Science Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Maxwell Life Science Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 79/100, distress signals and MSME payment-delay disclosures - know whether Maxwell Life Science Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Maxwell Life Science Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Maxwell Life Science Limited an active company?
Maxwell Life Science Limited has MCA status “Active” with a compliance score of 64/100 (Moderate).
Is Maxwell Life Science Limited financially healthy?
Maxwell Life Science Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Maxwell Life Science Limited?
Its overall Trust Score is 79/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Maxwell Life Science Limited?
Promoters hold a minority stake - exact percentages are in the full report. 7 active director(s) are on record.
Does Maxwell Life Science Limited have loans or charges against its assets?
7 open charge(s) are registered against its assets, and 8 earlier charge(s) stand satisfied.
Is Maxwell Life Science Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 64/100 (Moderate).
Is it risky to lend to Maxwell Life Science Limited?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
